- Home
- PCRX vs SPB Comparison
PCRX vs SPB Comparison
Compare PCRX & SPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- SPB
- Stock Information
- Founded
- PCRX 2006
- SPB 1906
- Country
- PCRX United States
- SPB United States
- Employees
- PCRX N/A
- SPB N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- SPB Industrial Machinery/Components
- Sector
- PCRX Health Care
- SPB Miscellaneous
- Exchange
- PCRX Nasdaq
- SPB Nasdaq
- Market Cap
- PCRX 1.2B
- SPB 1.3B
- IPO Year
- PCRX 2011
- SPB N/A
- Fundamental
- Price
- PCRX $23.63
- SPB $52.32
- Analyst Decision
- PCRX Buy
- SPB Strong Buy
- Analyst Count
- PCRX 5
- SPB 4
- Target Price
- PCRX $32.40
- SPB $79.50
- AVG Volume (30 Days)
- PCRX 532.5K
- SPB 371.1K
- Earning Date
- PCRX 11-05-2025
- SPB 11-14-2025
- Dividend Yield
- PCRX N/A
- SPB 3.59%
- EPS Growth
- PCRX N/A
- SPB N/A
- EPS
- PCRX N/A
- SPB 2.71
- Revenue
- PCRX $705,848,000.00
- SPB $2,849,200,000.00
- Revenue This Year
- PCRX $7.36
- SPB N/A
- Revenue Next Year
- PCRX $10.07
- SPB $0.77
- P/E Ratio
- PCRX N/A
- SPB $19.34
- Revenue Growth
- PCRX 2.25
- SPB N/A
- 52 Week Low
- PCRX $15.16
- SPB $50.73
- 52 Week High
- PCRX $27.64
- SPB $96.62
- Technical
- Relative Strength Index (RSI)
- PCRX 32.49
- SPB 44.98
- Support Level
- PCRX $24.31
- SPB $51.98
- Resistance Level
- PCRX $26.05
- SPB $55.32
- Average True Range (ATR)
- PCRX 0.76
- SPB 1.39
- MACD
- PCRX -0.33
- SPB 0.12
- Stochastic Oscillator
- PCRX 6.34
- SPB 21.44
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About SPB Spectrum Brands Holdings Inc.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.